Parkinson’s Disease Drug Market is expected to grow at a significant CAGR in the upcoming years as the scope and its applications are rising enormously across the globe. Parkinson’s disease (PD) is termed as a neurodegenerative disorder that affects dopaminergic neurons in a precise area of the brain called substantia nigra. Medicines are the most common treatment for Parkinson’s disease. There are numerous drugs available to treat both motor and non-motor symptoms of Parkinson ’s disease and all are directed at easing symptoms and improving quality of life.
Browse Full TOC of This Report @ https://www.millioninsights.com/industry-reports/Parkinson-s-disease-pd-drug-market
The factors that are playing a major role in the growth of Parkinson’s Disease Drug Market are rising life expectancy, rising funding support & research grants, growing healthcare expenditure, and rising awareness. In addition, growing old age population and rising incidences of neurodegenerative diseases are the other factors driving the industry. On the other hand, the high cost of treatment, lack of expertise, and side effects of drugs are the factors restraining overall market growth.
Parkinson’s Disease Drug Market is segmented based on drug types, distribution channel, end users, applications, and region. Drug types such as Anticholinergics (Benztropine or Trihexyphenidyl), Levodopa/Carbidopa, COMT-Inhibitors (Entacapone, Tolcapone), Amantadine, Dopamine Agonists (Ropinirole or Pramipexole), MAO-B Inhibitors (Selegiline, Rasagiline), Apomorphine, and others classify this market.
The key players of Parkinson’s Disease Drug Industry are Valeant Pharmaceuticals, GSK, US WorldMeds, Novartis, StadaArzneimittel, BoehringerIngelheim, Orion, Teva Pharmaceutical, Apokyn, Abbvie, Valeant, Merck, Lundbeck, Akorn, Hoffmann-La Roche, Kyowa Hakko Kirin Pharma, Endo Pharmaceuticals, Astellas Pharma, and DesitinArzneimittel. These players are concentrating on inorganic growth to sustain themselves amongst fierce competition. As such, mergers, acquisitions, and joint ventures are the need of the hour.
Request a Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/Parkinson-s-disease-pd-drug-market/request-sample